DOI: 10.36347/sjams.2023.v11i09.002

Pages: 1600-1604

Background: The thickening of the extensor retinaculum, which normally keeps the tendon in place in the wrist, can lead to de Quervain's tenosynovitis. The problem can be treated surgically as well as by other means. Injection of corticosteroids is an excellent conservative therapy choice. Objective: To the effect of intralesional corticosteroid injection in management of De Quervain's disease Methods: This randomized clinical trial was conducted with 60 adult patients eithermale or female diagnosed as a case of De Quervain's disease (moderate to severe pain) attending outpatient department of Physical Medicine and Rehabilitation in DMCH for six months period. Intra lesional corticosteroid injections were given with 1cc syringe between the synovial sheath and the tendons, during the initial visit. The patients were advised to follow the ADL instructions for the affected hand as much as possible. Outcome was measured by Visual Analogue Scale (VAS) and Patient Rated Wrist Evaluation (PRWE) scale. Every patient was assessed every weekly for 6 weeks. Level of significance was assessed with the help of paired t-test and chi-square test where necessary. Results: Out of the 60 patients, 36.67% were between the ages of 41 and 45, and 28.33% were between the ages of 46 and 50, with a mean age of 41.775.43 years. The number of men to women was 1:7.6. More than half of the patients (53%) had the disease in their right hand, while 42% had it in their left hand and 5% had it in both. 83.33% of patients who got an intralesional injection of methyl prednisolone acetate felt less pain. Conclusion: Treatment of de Quervain's tenosynovitis with intravenous triamcinolone is effective without surgery. The right injection technique and long-term monitoring need additional focus.